QUICK RNER SUMMARY:
1). SHARE STRUCTURE (52,000,000 O/S)
A). 10,000,000
"In April 2006, we issued 5,000,000 shares of common stock were issued to Shu-Heng Wang, one of our former officers and directors and in April 2006 we issued 5,000,000 shares of common stock to Jean Jin, one of our former officers and directors."
B). 10,000,000
"In October 2007, we completed our public offering issued 10,000,000 shares of common stock to 42 persons in consideration of $100,000."
C). 32,000,000
"In April 2009, the Company has issued 32 million restricted common shares to the designated party of Beijing RainEarth Technology Co. Ltd."
2). OPERATIONS (Manufacturing Facility + Office)
A). "China RainEarth’s manufacturing operations are located in 18 Keyuan Road, the Industrial Development Zone of Huangcun Town, Daxing District, Beijing, China. The facility consists of a manufacturing plant with capabilities of producing blood dialysis. China RainEarth began commercial manufacturing from this facility in 2005. Currently China RainEarth can produce about 150,000 pieces of blood dialyzers annually from this facility."
B). "Our office is located at A No.1 Building, ShangDu International Tower, No.8 DongDaQiao Road, Beijing, China 100020. This is our mailing address as well. Our telephone number is (852) 3005-7220."
3). PATENTS
China RainEarth applied for and was approved for patents for its core technology with the State Intellectual Property Office of P.R.C. (SIPO). These patents include:
-- Mass production method for hollow fiber membranes
-- Quick cleaning equipment for hollow fiber membranes
-- Quick drying equipment for hollow fiber membranes
-- Device for adjusting dry spinning range in hollow fiber membrane dry-wet spinning and control condensation bath process concentration control
-- Manufacturing technique for blended PES hollow fiber dialysis membrane
-- Synthetic hollow fiber membrane continuous spinning device
-- Hollow fiber membrane porous spinneret component
-- Hollow fiber tube-in-orifice spinneret
4). CONTRACTS
"China RainEarth has been contracted to manufacture and deliver 80,000 dialyzers for medical use at HangZhou No.3 Hospital. These high quality fibers will be delivered within two months of the signing date. Each dialyzer is valued at approximately $60.00RMB (approximately $8.75USD), which brings the total contract value to $4,800,000 RMB (approximately $703,000USD)."
"RainEarth Inc.(OTC Bulletin Board: RNER; "the Company"), announced today that its contractual partner in China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"), and XiangFan Municipal No.1 People's Hospital, entered into a Purchase Agreement (the "Agreement") for an amount of RMB1,800,000(approximately $263,500) for its blood dialyzers."
5). FAQ
Q: What is China RainEarth's advantage? What are China RainEarth's
qualifications?
A: With 8 years of research and development by the founders of China
RainEarth, they have become the only company in China that has mastered
chemical formula and technique of hollow fiber separation membranes as well as
the design and development capabilities for production equipment of hollow
fiber separation membranes. Currently their hollow fiber separation membrane
has passed China Compulsory Certification and tests by the State Food and Drug
Administration in China.
Since China RainEarth has proprietary fiber membrane manufacturing techniques
(only German Company: Fresenius can independently manufacture fiber membrane
production equipment) and the capabilities to design and develop assembly and
production lines, no need to import expensive equipment, therefore, the
products will have strong cost advantage. Also, dialyzers manufactured by
China RainEarth have undergone clinical experiments and CCC certification, and
obtained registration certificates. China RainEarth has also completed all
tests and clinical experiments necessary for CE certification, and is
qualified to export its products.
Q: What is China RainEarth's management team?
A: Following are the brief introductions about China RainEarth's management
team:
General Manager: Mr. Liu Wei He has more than 15 years of work experience in
medicine and blood purification and several years of work experience in market
development and Mainland business affairs management when working in "Song Ho"
Company, the largest blood purification group company in Japan and has
participated in the establishment of the first Sino-foreign cooperative
hemodialysis center in China.
Technical Principal: Mr. Jiang Naiqing: He has worked in the units of Dandong
Chemical Fiber Plant, Ministry of China Textile Industry, Beijing Chemical
Fiber Plant, Beijing Institute of Fashion Technology, etc. and specialized in
the research and development of chemical fibers. Since the year of 2000, he
has committed himself to the research of hollow fiber technology and has
served as a General Engineer in Doreson Medical in Shanghai, and designed and
manufactured on his own a polysulphone membrane hollow fiber spinning
production line and a matching dialyzer assembly line, which have come up to
the level for industrialized production, with them, real finished
products----dialyzers have been produced.
Lead Engineer: Mr. Yu Xuesong: He has more than 20 years of work experience in
mechanically and automatically controlled systems and has worked as a Senior
Engineer in the General Engineering Design & Research Institute of the
People's Liberation Army General Armament Department to deal with
mechanical-electrical integration and the development and application of
mechanically and automatically controlled systems particularly. He has led the
design and development of the first "comprehensive blood purification
therapeutic machine" in China which is mainly used for treating lupus
erythematosus, immunological diseases like rheumatoid disease and part of
infectious diseases.
Lead Engineer: Mr. Zhou Yue: He has more than 20 years of work experience in
automatically-controlled system and high-voltage pulse field and more than 15
years of experience in researching and developing extracorporeal
lithotripters, has led the design and development of "shock-wave pain
therapeutic-apparatus" and has the patent for manufacturing special electrodes
applied to the shock-wave pain therapeutic-apparatus.
Medical Adviser: Professor Wang Zhigang: He is the Director of the Blood
Purification Center of former Friendship Hospital and an authoritative blood
purification expert in China.
Technical Advisor: Professor Sun Benhui: He is a senior professor and a
doctoral tutor of Beijing University of Chemical Technology and an
authoritative expert in the field of membranes for separation in China.
Management Representative: Mr. Jiang Hua: He is proficient on fibrous membrane
production and has extensive contact with the upstream and downstream
enterprises of blood purification industry.
AI
